Lung Cancer Update podcast

Artwork

Oncology Lung Cancer Science Medicine Fitness Podcasting Education Research And Practical

Player FM - Internet Radio Done Right

108 subscribers

Tilføjet twelve år siden

Indhold leveret af Dr. Neil Love. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af Dr. Neil Love eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.

T

The Agile Brand with Greg Kihlström®: Expert Mode Marketing Technology, AI, & CX

1
#755: Sitecore CMO Michelle Boockoff-Bajdek and Microsoft's Talisha Padgett on designed intelligence for marketing 27:13

for 13 dage siden27:13

27:13

In the race to adopt AI, how do we avoid creating a sea of sameness and alienating the very customers we're trying to connect with? Today, we're going to talk about the intentional design of our marketing future. We’ll explore how leading brands are moving beyond the hype of AI to build practical, collaborative frameworks between humans and machines, shifting from outdated customer segments to real-time signals, and ultimately, creating experiences that are not only efficient but deeply empathetic and relevant. To help me discuss this topic, I'd like to welcome, Michelle Boockoff-Bajdek, CMO at Sitecore and Talisha Padgett, GM MArTech, AI & Automation at Microsoft, who will be doing a fireside chat at the upcoming Sitecore Symposium, November 3-5 in Orlando Florida. We’re going to get a sneak preview today of some of the topics they’ll be discussing. About Michelle Boockoff-Bajdek and Talisha Padgett Michelle Boockoff-Bajdek on LinkedIn: https://www.linkedin.com/in/michellebb/ Talisha Padgett on LinkedIn: https://www.linkedin.com/in/talishapadgett/ Resources Sitecore: https://www.sitecore.com Register now for Sitecore Symposium, November 3-5 in Orlando, Florida. Use code SYM25-2Media10 to receive 10% off. Go here for more: https://symposium.sitecore.com/ Catch the future of e-commerce at eTail Palm Springs, Feb 23-26 in Palm Springs, CA. Go here for more details: https://etailwest.wbresearch.com/ Connect with Greg on LinkedIn: https://www.linkedin.com/in/gregkihlstrom Don't miss a thing: get the latest episodes, sign up for our newsletter and more: https://www.theagilebrand.show Check out The Agile Brand Guide website with articles, insights, and Martechipedia, the wiki for marketing technology: https://www.agilebrandguide.com The Agile Brand is produced by Missing Link—a Latina-owned strategy-driven, creatively fueled production co-op. From ideation to creation, they craft human connections through intelligent, engaging and informative content. https://www.missinglink.company…

Lung Cancer Update

Del

Serier hjem•Feed

Indhold leveret af Dr. Neil Love. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af Dr. Neil Love eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.

Featuring one-on-one interviews conducted by Dr Neil Love, this series bridges the gap between research and patient care by providing medical oncologists, hematologists and hematology/oncology fellows ongoing access to the perspectives and opinions of national and international research leaders with an expertise in thoracic oncology.

… continue reading

95 episoder

#Oncology #Lung #Cancer #Science #Medicine #Fitness #Podcasting Education #Research And Practical

Artwork

Lung Cancer Update

108 subscribers

updated for 16 dage siden

Del

Serier hjem•Feed

Indhold leveret af Dr. Neil Love. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af Dr. Neil Love eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.

Featuring one-on-one interviews conducted by Dr Neil Love, this series bridges the gap between research and patient care by providing medical oncologists, hematologists and hematology/oncology fellows ongoing access to the perspectives and opinions of national and international research leaders with an expertise in thoracic oncology.

… continue reading

95 episoder

#Oncology #Lung #Cancer #Science #Medicine #Fitness #Podcasting Education #Research And Practical

Alle episoder

×

Artwork

1
Lung Cancer — 5-Minute Journal Club Issue 3 with Dr Aaron Lisberg: Defining the Role of TROP2-Directed Antibody-Drug Conjugates 24:47

for 16 dage siden24:47

24:47

Dr Aaron Lisberg from the University of California, Los Angeles discusses recent developments with TROP2-directed antibody-drug conjugates in the management of non-small cell lung cancer. CME information and select publications here .

Artwork

1
Non-Small Cell Lung Cancer — 5-Minute Journal Club Issue 2 with Dr Jacob Sands: Defining the Role of TROP2-Directed Antibody-Drug Conjugates 23:19

for 7 weeks siden23:19

23:19

Dr Jacob Sands from Dana-Farber Cancer Institute in Boston, Massachusetts, discusses recent developments with TROP2-directed antibody-drug conjugates in the management of lung cancer. CME information and select publications here .

Artwork

1
Small Cell Lung Cancer — Expert Perspectives on Actual Patient Cases 58:18

for 11 weeks siden58:18

58:18

Dr Stephen V Liu from Georgetown University Hospital in Washington, DC and Dr Charles Rudin from Memorial Sloan Kettering Cancer Center in New York discuss the role of approved and novel investigational therapies for patients with limited-stage and extensive-stage small cell lung cancer. CME information and select publications here .…

Artwork

1
Non-Small Cell Lung Cancer — 5-Minute Journal Club Issue 1 with Dr Jacob Sands: Defining the Role of TROP2-Directed Antibody-Drug Conjugates 17:44

for 11 weeks siden17:44

17:44

Dr Jacob Sands from Dana-Farber Cancer Institute in Boston, Massachusetts, discusses recent developments with TROP2-directed antibody-drug conjugates in the management of non-small cell lung cancer. CME information and select publications here .

Artwork

1
Non-Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances 59:02

for 13 weeks siden59:02

59:02

Dr Benjamin Levy from Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial in Washington, DC, discusses important efficacy and safety data from 2024 related to the use of approved and investigational therapies for localized and advanced non-small cell lung cancer without a targetable mutation. CME information and select publications here .…

Artwork

1
Lung Cancer — Proceedings from a Session Held During the 2025 ASCO Annual Meeting on the Current and Future Role of Immunotherapy and Antibody-Drug Conjugates 1:28:41

for 16 weeks siden1:28:41

1:28:41

Prof Marina Garassino, Dr John Heymach, Prof Solange Peters and moderator Dr Jacob Sands present key data from the ASCO 2025 Annual Meeting on the management of metastatic NSCLC without targetable mutations, as well as emerging evidence on the role of antibody-drug conjugates for patients with select actionable genomic alterations. CME information and select publications here .…

Artwork

1
For Oncology Nurses: DLL3-Targeting Bispecific T-Cell Engagers for Small Cell Lung Cancer — Proceedings from the 2025 Annual ONS Congress 1:27:39

for 17 weeks siden1:27:39

1:27:39

Dr Anne Chiang, Dr Erin Schenk, and nurse practitioners Ms Elizabeth Krueger and Ms Beth Sandy discuss the role of bispecific antibodies in the management of small cell lung cancer and strategies to mitigate and manage treatment-emergent adverse events. NCPD information and select publications here .…

Artwork

1
EGFR Mutation-Positive Non-Small Cell Lung Cancer — Proceedings from a Session Held During the 2025 ASCO Annual Meeting 1:57:51

for 20 weeks siden1:57:51

1:57:51

Prof Nicolas Girard, Dr Jonathan Goldman, Dr Pasi Jänne, Dr Suresh Ramalingam, Dr Joshua Sabari and moderator Dr Helena Yu present data informing treatment decision-making for EGFR-mutated NSCLC at the 2025 ASCO annual meeting. CME information and select publications here .

Artwork

1
Non-Small Cell Lung Cancer and Therapeutic Targets Beyond EGFR — Year in Review Series on Relevant New Datasets and Advances 58:22

for 21 weeks siden58:22

58:22

Dr Jessica J Lin from Massachusetts General Hospital in Boston and Dr Joel W Neal from Stanford Cancer Institute in California summarize major treatment advances over the past year and review relevant ongoing clinical trials using targeted therapies for patients with non-small cell lung cancer. CME information and select publications here .…

Artwork

1
Immunotherapy and Nontargeted Approaches for NSCLC — Fourth Annual National General Medical Oncology Summit 50:15

for 24 weeks siden50:15

50:15

Clinical investigators discuss available data guiding the management of non-small cell lung cancer with immunotherapy and other nontargeted approaches. CME information and select publications here .

Artwork

1
EGFR Mutation-Positive NSCLC — Fourth Annual National General Medical Oncology Summit 52:17

for 27 weeks siden52:17

52:17

Clinical investigators discuss available data guiding the management of EGFR mutation-positive non-small cell lung cancer. CME information and select publications here .

Artwork

1
For Oncology Nurses: Antibody-Drug Conjugates for Breast Cancer and Lung Cancer — Proceedings from the 2025 Annual ONS Congress 1:33:02

for 28 weeks siden1:33:02

1:33:02

Dr Edward B Garon, Dr Tiffany A Traina, and nurse practitioners Ms Marianne J Davies and Ms Marissa Marti-Smith discuss the role of antibody-drug conjugates in the care of patients with breast and lung cancer and strategies to mitigate and manage treatment-emergent adverse events. NCPD information and select publications here .…

Artwork

1
First-Line Therapy for Metastatic Non-Small Cell Lung Cancer and an ALK Rearrangement — An Interview with Dr Justin F Gainor 57:28

for 30 weeks siden57:28

57:28

Dr Justin F Gainor from Massachusetts General Hospital in Boston reviews available clinical data on ALK inhibitors and first-line treatment strategies for ALK-positive metastatic non-small cell lung cancer. CME information and select publications here .

Artwork

1
EGFR-Mutant Non-Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances 1:00:02

for 39 weeks siden1:00:02

1:00:02

Dr Enriqueta Felip from the Vall d’Hebron Institute of Oncology in Barcelona, Spain, and Dr Helena Yu from Memorial Sloan Kettering Cancer Center in New York, New York, discuss current and emerging treatment approaches for patients with EGFR-mutant non-small cell lung cancer. CME information and select publications here…

Artwork

1
Cases from the Community: Integrating New Research Findings into Current Practice — Lung Cancer 48:03

for 47 weeks siden48:03

48:03

Dr Edward B Garon shares his perspectives on the evolving therapeutic landscape for patients with lung cancer.

Velkommen til Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

Lyt til 500+ emner

Lyt til dette show, mens du udforsker